|Fastest Growing Market:||Asia Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The enteral feeding devices market was valued at approximately USD 2,850 million in 2020 and is expected to witness a revenue of USD 3,985 million in 2026, with a CAGR of 6.2% over the forecast period (2021-2026).
The current pandemic of COVID-19 is expected to significantly impact the enteral feeding devices market globally. According to the research article published in Critical Care, 2020, the SARS-CoV2 virus infects the respiratory tract and is also predicted to invade the gastrointestinal tract, neurological systems, and kidneys, which may affect the nutrition delivery among COVID-19 patients. According to the guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) on nutrition in the ICU, Gastric Enteral Nutrition is advised for severe COVID-19 patients and should be preferably performed using a pump with a flow regulator, within 48 hours of admission to the ICU. Hence, the COVID-19 pandemic has increased the need for enteral feeding devices, especially for those in intensive care units, and thus, has been driving the studied market.
The factors that are responsible for the growth of the market include an increasing population of geriatrics, higher premature births, growing adoption of enteral nutrition, and higher prevalence of chronic diseases.
The global population is aging at a fast pace due to reduced birth rates and increasing life expectancy. According to the United Nations’ World Population Ageing 2019 report, there were an estimated 703 million people aged 65 years, globally, in 2019, and this number is expected to reach to 1.5 billion by 2050. As an alternative to conventional nutritional intake, enteral feeding is administered to elderly patients who have difficulty in swallowing, digestion, and assimilation, and thus, this increase of the geriatric population acts as a major factor for the growth of the studied market.
Additionally, according to World Health Organization, 2018, an estimated 15 million babies are born preterm every year and this number is expected to rise over the years. The premature babies have higher nutritional requirements in the neonatal period and early initiation of enteral nutrition could benefit premature babies. Hence, in view of the aforementioned factors, the enteral feeding devices market is expected to witness a significant growth over the forecast period.
Scope of the Report
Enteral feeding refers to the delivery of a nutritionally complete feed, containing protein, carbohydrate, fat, water, minerals, and vitamins, directly into the stomach, duodenum, or jejunum through devices, such as tubes and pumps. It is used for people with functional GI tract, who are not able to ingest foods orally to meet their nutrient demand. The enteral feeding devices market is segmented by product type, age group, end users, application, and geography. By product type, the market is segmented by enteral feeding pumps, enteral feeding tubes, and other product types. By age group, the market is segmented by adults and pediatrics. by end user, the market is segmented by hospitals, ambulatory care services, and other end users. By application, the market is segmented by oncology, neurology, critical care, diabetes, gastroenterology, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
|By Product Type|
|Enteral Feeding Pumps|
|Enteral Feeding Tubes|
|Other Product Types|
|By Age Group|
|By End User|
|Ambulatory Care Services|
|Other End Users|
Key Market Trends
Application in Diabetes is Expected to Register a Good Growth during the Forecast Period
For patients with diabetes, the enteral feeding regimen is recommended by the dietitian to meet the individual’s nutritional requirements. Special high-protein diabetes-specific formulas are administered through the enteral feeding tubes, which reduce the insulin need for the patients. This leads to improved glycemic control, which is important for the longevity of the patient. Additionally, enteral nutrition lacks cholesterol and thereby aids in cholesterol control in diabetic patients. The development of insulin resistance can also be minimized using continuous saccharide delivery with appropriate caloric content. According to the research article published in Nutrients, in 2019, the Diabetes- Specific Formula has improved glycemic control through delay in gastric emptying, delayed intestinal absorption of carbohydrate and lower glycemic response, and was found to be effective in increasing High-Density Lipid (HDL) cholesterol levels. Furthermore, as per the research article published in the Lancet, Diabetes, and Endocrinology, 2020, the COVID-19 virus can severely affect diabetic patients as it can precipitate acute metabolic complications through direct negative effects on β-cell function. This impairment on the β-cell function can cause diabetic ketoacidosis in diabetic patients, hyperglycemia at hospital admission in individuals with unknown history of diabetes, and potentially new-onset diabetes, which is expected to surge the demand for enteral feeding devices for the management of diabetes. Hence, COVID-19 is expected to highly impact the studied segment during the pandemic.
Moreover, incidences of diabetes have increased over the years globally, and is expected to increase further. As per a 2019 report by the Internation Diabetes Federation, the global incidence of diabetes is expected to increase from 463 million in 2019 to 578 million by 2030. Thus, these factors play a major role in increasing the demand for enteral feeding devices, which will likely boost the market growth.
To understand key trends, Download Sample Report
North America is Expected to Dominate the Enteral Feeding Devices Market Over the Forecast Period
The North American region, particularly the United States has a developed and well-structured health care system. The region is a hub for research and development activities and encourages key players to establish their headquarters in the region through its policies and investment support . As a result, these countries enjoy the presence of many global market players.
Also, the growing burden of chronic diseases and geriatric population in the region is expected to drive the demand for enteral feeding devices, to support the nutritional requirements of individuals who can not ingest and digest food. According to the Population Reference Bureau's Population Bulletin" Aging in the United States the Americans aged 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. The current pandemic of COVID-19 is expected to propel the use of enteral feeding devices market in the United States. The highest number of COVID-19 infected patients as per John Hopkins COVID-19 Tracker are reported in the United States and as Enteral nutrition is recommended by the Society of Critical Care Medicine and the American Society for Parenteral and Enteral Nutrition, over the first few weeks of critical illness by COVID-19 infection, to meet the energy goal of 15-20kcal/Kg actual body weight/dayand protein goal of 1.2-2.0 gm/kg ABW/day. Hence, Enteral feeding devices market is expected to propel over the current COVID-19 pandemic era.
Additionally, the increasing product approvals is expected to drive the market growth. For instance, in Oct 2019, Fidmi Medical received 510(k) clearancefrom FDA for its low-profile enteral feeding device, a gastronomy tube designed to deliver nutrients to patients. Thus, in view of the aforementioned factors, th estudied market is expected to propel significantly in North America overthe forecast period.
To understand geography trends, Download Sample Report
The enteral feeding devices market is highly competitive. In terms of market share, several companies, such as B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cardinal Health, and Becton Dickinson and Company, among others, hold the largest market shares. The key players are evolving through various strategic alliances, such as acquisitions, collaborations, and new product launches, to expand the global product portfolio and secure their positions in the global market.
In September 2020, Amsino International Inc. obtained FDA approval for its PUGGLE Enteral Feeding Pump and Feeding Set, which is intended to deliver the nutritional formula to the gastrointestinal system of a patient of infant age and older who is physically unable to eat and swallow.
In June 2020, Wilson-Cook Medical, Inc received UD FDA 510(k) clearance for its Entuit Nasal Jejunal Feeding Tube intended to provide short-term enteral access for delivery of nutrition and/or medications to small bowel in adults.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Chronic Diseases
4.2.2 Increasing Number of Premature Births
4.2.3 Growing Demand for Enteral Feeding in Home Care Settings
4.3 Market Restraints
4.3.1 Complications Associated with Enteral Feeding Tubes
4.3.2 Healthcare Reimbursement Issues
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Enteral Feeding Pumps
5.1.2 Enteral Feeding Tubes
5.1.3 Other Product Types
5.2 By Age Group
5.3 By End User
5.3.2 Ambulatory Care Services
5.3.3 Other End Users
5.4 By Application
5.4.3 Critical Care
5.4.6 Other Applications
5.5.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.5.4 Middle East & Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle East & Africa
5.5.5 South America
220.127.116.11 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 B. Braun Melsungen AG
6.1.3 Boston Scientific Corporation
6.1.4 Conmed Corporation
6.1.5 Cook Medical Inc.
6.1.6 Fresenius SE & Co. KGaA
6.1.7 Halyard Health Inc.
6.1.8 Danone Medical Nutrition (Nutricia)
6.1.9 Moog Inc.
6.1.10 Nestle SA
6.1.11 Avanos Medical, Inc.
6.1.12 Cardinal Health, Inc.
6.1.13 Becton Dickinson and Company
6.1.14 Vygon SA
6.1.15 Applied Medical technology, Inc.
6.1.16 Amsino International Inc.
6.1.17 Fidmi Medical
6.1.18 ALCOR Scientific, Inc.
6.1.19 MEDELA Inc
6.1.20 Vesco Medical LLC
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Global Enteral Feeding Devices Market market is studied from 2018 - 2026.
What is the growth rate of Global Enteral Feeding Devices Market?
The Global Enteral Feeding Devices Market is growing at a CAGR of 6.2% over the next 5 years.
Which region has highest growth rate in Global Enteral Feeding Devices Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Enteral Feeding Devices Market?
North America holds highest share in 2020.
Who are the key players in Global Enteral Feeding Devices Market?
B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Becton Dickinson and Company, Cardinal Health, Inc. are the major companies operating in Global Enteral Feeding Devices Market.